nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

11.05.2023 | Original Article

Molecular and in silico analyses of SYN III gene variants in autism spectrum disorder

verfasst von: Remzi Oguz Baris, Nilfer Sahin, Ayşegül Demirtas Bilgic, Cilem Ozdemir, Tuba Gokdogan Edgunlu

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Defects in neurotransmission and synaptogenesis are noteworthy in the pathogenesis of ASD. Synapsin III (SYN III) is defined as a synaptic vesicle protein that plays an important role in synaptogenesis and regulation of neurotransmitter release and neurite outgrowth. Therefore, SYN III may associate with many neurodevelopmental diseases, including ASD.

Aim

The aim of this study was to investigate whether the SYN III gene -631 C > G (rs133946) and -196 G > A (rs133945) polymorphisms are associated with susceptibility to ASD.

Methods

SYN III variants and the risk of ASD were investigated in 26 healthy children and 24 ASD children. SYN III gene variants were genotyped by PCR–RFLP methods. The differences in genotype and allele frequencies between the ASD and control groups were calculated using the chi-square (χ2). We analysed the SYN III gene using web-based tools.

Results

Our results suggest that the presence of the AA genotype of the SYN III -196 G > A (rs133945) polymorphism affects the characteristics and development of ASD in children (p = 0.012). SYN III -631 C > G (rs133946) polymorphism was not associated with ASD (p = 0.524). We have shown the prediction of gene–gene interaction that SYN III is co-expressed with 17 genes, physical interaction with 3 genes, and co-localization with 12 genes. The importance of different genes (SYN I, II, III, GABRD, NOS1AP, GNAO1) for ASD pathogenesis was revealed by GO analysis.

Conclusion

Considering the role of SYN III and related genes, especially in the synaptic vesicle pathway and neurotransmission, its effect on ASD can be further investigated.

Chen JA, Peñagarikano O, Belgard TG et al (2015) The emerging picture of autism spectrum disorder: genetics and pathology. Annu Rev Pathol 10:111–144CrossRefPubMed

Geschwind DH (2011) Genetics of autism spectrum disorders. Trends Cogn Sci 15(9):409–416CrossRefPubMedPubMedCentral

Lord C, Elsabbagh M, Baird G et al (2018) Autism spectrum disorder. Lancet 392(10146):508–520CrossRefPubMedPubMedCentral

Ivanov HY, Stoyanova VK, Popov NT et al (2015) Autism spectrum disorder - a complex genetic disorder. Folia Med (Plovdiv) 57(1):19–28CrossRefPubMed

Şahın N, Kara M, Kara B, Topal H (2018) Evaluation of RELN gene polymorphism in children with autism spectrum disorder. Anadolu Psikiyatri Dergisi 19:599–606

Ecker C (2017) The neuroanatomy of autism spectrum disorder: an overview of structural neuroimaging findings and their translatability to the clinical setting. Autism 21(1):18–28CrossRefPubMed

Bourgeron T (2015) From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci 16(9):551–563. https://doi.org/10.1038/nrn3992CrossRefPubMed

Özdemir Ç, Şahin N, Edgünlü T (2022) Vesicle trafficking with snares: a perspective for autism. Mol Biol Rep 49(12):12193–12202CrossRefPubMed

Salpietro V, Malintan NT, Llano-Rivas I et al (2019) Mutations in the neuronal vesicular SNARE VAMP2 affect synaptic membrane fusion and impair human neurodevelopment. Am J Hum Genet 104(4):721–730CrossRefPubMedPubMedCentral

10.

Nakamura K, Iwata Y, Anitha A et al (2011) Replication study of Japanese cohorts supports the role of STX1A in autism susceptibility. Prog Neuropsychopharmacol Biol Psychiatry 35(2):454–458CrossRefPubMed

11.

Safari MR, Omrani MD, Noroozi R et al (2017) Synaptosome-associated protein 25 (SNAP25) gene association analysis revealed risk variants for ASD. Iranian population J Mol Neurosci 61(3):305–311

12.

Fujiwara T, Snada M, Kofuji T et al (2010) HPC-1/syntaxin 1A gene knockout mice show abnormal behavior possibly related to a disruption in 5-HTergic systems. Eur J Neurosci 32(1):99–107CrossRefPubMed

13.

Greco B, Managò F, Tucci V et al (2013) Autism-related behavioral abnormalities in synapsin knockout mice. Behav Brain Res 251:65–74. https://doi.org/10.1016/j.bbr.2012.12.015CrossRefPubMedPubMedCentral

14.

Chen J, Yu S, Fu Y et al (2014) Synaptic proteins and receptors defects in autism spectrum disorders. Front Cell Neurosci 8:276CrossRefPubMedPubMedCentral

15.

Tang BL (2020) SNAREs and developmental disorders. J Cell Physiol 236(4):2482–2504. https://doi.org/10.1002/jcp.30067CrossRefPubMed

16.

Feng J, Chi P, Blanpied TA et al (2002) Regulation of neurotransmitter release by synapsin III. J Neurosci 22(11):4372–4380. https://doi.org/10.1523/JNEUROSCI.22-11-04372.2002CrossRefPubMedPubMedCentral

17.

Michetti C, Caruso A, Pagani M et al (2017) The knockout of synapsin II in mice impairs social behavior and functional connectivity generating an ASD-like phenotype. Cereb Cortex 27(10):5014–5023. https://doi.org/10.1093/cercor/bhx207CrossRefPubMed

18.

Lee E, Lee J, Kim E (2017) Excitation/inhibition imbalance in animal models of autism spectrum disorders. Biol Psychiat 81(10):838–847CrossRefPubMed

19.

Alymov AA, Kapitsa IG, Voronina TA (2021) Neurochemical mechanisms of pathogenesis and pharmacological correction of autism spectrum disorders: current concepts and prospects. Neurochem J 15(2):129–138. https://doi.org/10.1134/S1819712421020033CrossRef

20.

Porton B, Wetsel WC, Kao HT (2011) Synapsin III: role in neuronal plasticity and disease. Semin Cell Dev Biol 22(4):416–424. https://doi.org/10.1016/j.semcdb.2011.07.007CrossRefPubMedPubMedCentral

21.

Kenar ANI, Edgünlü T, Herken H et al (2013) Association of synapsin III gene with adult attention deficit hyperactivity disorder. DNA Cell Biol 32(8):430–434CrossRefPubMed

22.

Warde-Farley D, Donaldson SL, Comes O et al (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38(Web Server issue):W214–W220

23.

Gilani N, Belaghi RA, Aftabi Y et al (2021) Identifying potential miRNA biomarkers for gastric cancer diagnosis using machine learning variable selection approach. Front Genet 12

24.

Kile BM, Guillot TS, Venton BJ et al (2010) Synapsins differentially control dopamine and serotonin release. J Neurosci 30(29):9762–9770CrossRefPubMedPubMedCentral

25.

Ferreira A, Kao HT, Feng J et al (2000) Synapsin III: developmental expression, subcellular localization, and role in axon formation. J Neurosci 20(10):3736–3744CrossRefPubMedPubMedCentral

26.

Kao HT, Li P, Chao HM et al (2008) Early involvement of synapsin III in neural progenitor cell development in the adult hippocampus. J Comp Neurol 507(6):1860–1870CrossRefPubMed

27.

Ekinci A, Ekinci O, Turkcarpar H et al (2012) Emotional schemas and their relationship with clinical characteristics in patients with alcohol dependence/Alkol bagimlisi olgularin saglikli kontrollerle emosyonel semalar yonunden karsilastirilmasi ve klinik ozelliklerle iliskisi. Noro Psikiyatr Ars 49(4):286–294

28.

Başay Ö, Kabukcu Basay B, Alacam H et al (2016) The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients. Neuropsychiatr Dis Treat 12:1141–1149PubMedPubMedCentral

29.

Porton B, Ferreira A, DeLisi LE et al (2004) A rare polymorphism affects a mitogen-activated protein kinase site in synapsin III: possible relationship to schizophrenia. Biol Psychiatry 55(2):118–125CrossRefPubMed

30.

Hall H, Lawyer G, Sillen A et al (2007) Potential genetic variants in schizophrenia: a Bayesian analysis. World J Biol Psychiatry 8(1):12–22CrossRefPubMed

31.

Akkad DA, Gödde R, Epplen JT (2006) No association between synapsin III gene promoter polymorphisms and multiple sclerosis in German patients. J Neurol 253(10):1365–1366CrossRefPubMed

32.

Otaegui D, Zuriarrain O, Castillo-Trivino T et al (2009) Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients. Mult Scler 15(1):124–128CrossRefPubMed

33.

Bolat H, Ünsel-Bolat G, Özgül S et al (2022) Investigation of possible associations of the BDNF, SNAP-25 and SYN III genes with the neurocognitive measures: BDNF and SNAP-25 genes might be involved in attention domain, SYN III gene in executive function. Nord J Psychiatry 1–6

34.

Edgünlü TG, Özge A, Yalin OÖ et al (2012) Genetic variants of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer’s disease. Noro Psikiyatr Ars 49(4)

35.

Giovedí S, Corradi A, Fassio A et al (2014) Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: the case of synapsins. Front Pediatr 2:94PubMedPubMedCentral

36.

Ahring PK, Liao VW, Gardella E et al (2022) Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy. Brain 145(4):1299–1309CrossRefPubMed

37.

Sesarini CV, Costa L, Naymark M et al (2014) Evidence for interaction between markers in GABA (A) receptor subunit genes in an A rgentinean autism spectrum disorder population. Autism Res 7(1):162–166CrossRefPubMed

38.

Lu ATH, Dai X, Martinez-Agosto JA et al (2012) Support for calcium channel gene defects in autism spectrum disorders. Mol autism 3(1):1–9CrossRef

39.

Delorme R, Betancur C, Scheid I et al (2010) Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls. BMC Med Genet 11(1):1–9CrossRef

40.

Hepler JR, Gilman AG (1992) G proteins. Trends Biochem Sci 17(10):383–387CrossRefPubMed

41.

Jiang M, Bajpayee NS (2009) Molecular mechanisms of go signaling. Neurosignals 17(1):23–41CrossRefPubMedPubMedCentral

42.

Jiang M, Gold MS, Boulay G et al (1998) Multiple neurological abnormalities in mice deficient in the G protein Go. Proc Natl Acad Sci 95(6):3269–3274CrossRefPubMedPubMedCentral

43.

Skafidas E, Testa R, Zantomio D et al (2014) Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry 19(4):504–510CrossRefPubMed

44.

Gerald B, Ramsey K, Belnap N et al (2018) Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: cautions in interpretation of genomic test results. In Semin Pediatr Neurol 26:28–32

45.

Schirinzi T, Garone G, Travaglini L et al (2019) Phenomenology and clinical course of movement disorder in GNAO1 variants: results from an analytical review. Parkinsonism Relat Disord 61:19–25CrossRefPubMed

46.

Danti FR, Galosi S, Romani M et al (2017) GNAO1 encephalopathy: broadening the phenotype and evaluating treatment and outcome. Neurol Genet 3:e143CrossRefPubMedPubMedCentral

47.

Muir AM, Myers CT, Nguyen NT et al (2019) Genetic heterogeneity in infantile spasms. Epilepsy Res 156:106181CrossRefPubMedPubMedCentral

48.

Marcé-Grau A, Dalton J, López-Pisón J et al (2016) GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females. Orphanet J Rare Dis 11(1):1–9CrossRef

49.

Lakhan R, Kalita J, Misra UK et al (2010) Association of intronic polymorphism rs3773364 A> G in synapsin-2 gene with idiopathic epilepsy. Synapse 64(5):403–408CrossRefPubMed

50.

O’Connell KS, McGregor NW, Lochner C et al (2018) The genetic architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism spectrum disorder. Mol Cell Neurosci 88:300–307CrossRefPubMed

51.

Sharma AR, Batra G, Saini L et al (2022) Valproic acid and propionic acid modulated mechanical pathways associated with autism spectrum disorder at prenatal and neonatal exposure. CNS Neurol Disord Drug Targets 21(5):399–408CrossRefPubMed

52.

Fassio A, Patry L, Congia S et al (2011) SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet 20(12):2297–2307CrossRefPubMed

Titel: Molecular and in silico analyses of SYN III gene variants in autism spectrum disorder
verfasst von: Remzi Oguz Baris
Nilfer Sahin
Ayşegül Demirtas Bilgic
Cilem Ozdemir
Tuba Gokdogan Edgunlu
Publikationsdatum: 11.05.2023
Verlag: Springer International Publishing
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 6/2023
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-023-03402-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Molecular and in silico analyses of SYN III gene variants in autism spectrum disorder

Abstract

Background

Aim

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2023

Association between lipocalin-2 levels and diabetic retinopathy in patients with overweight/obese type 2 diabetes mellitus

Efficacy of topical insulin for recurrent epithelial corneal erosions

Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital

A simple method to rapidly assess the tibial tuberosity—trochlear groove distance using computed tomography

Percutaneous revision of dysfunctional shunts in patients who underwent intrahepatic portosystemic shunt procedure via percutaneous or conventional method: 11-years single center experience

Characteristics of potential concussive events in elite hurling: a video-analysis study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin